Related Experiment Video

Updated: Mar 6, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.1K

Closer than ever to an Ebola virus vaccine

Logan Banadyga1, Andrea Marzi1

  • 1a Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases , National Institutes of Health , Hamilton , MT , USA.

Expert Review of Vaccines
|March 22, 2017
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Ebola virusVSV-EBOVcAd3-EBOfilovirusrVSV-ZEBOVvaccine

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

8.5K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
33.6K
Vaccinations01:51

Vaccinations

Overview
52.8K